Source:http://linkedlifedata.com/resource/pubmed/id/19515588
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-7-20
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1532-2165
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
141-2
|
pubmed:meshHeading |
pubmed-meshheading:19515588-Carotid Artery Diseases,
pubmed-meshheading:19515588-Cholesterol, HDL,
pubmed-meshheading:19515588-Cholesterol, LDL,
pubmed-meshheading:19515588-Endarterectomy, Carotid,
pubmed-meshheading:19515588-Humans,
pubmed-meshheading:19515588-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19515588-Recurrence,
pubmed-meshheading:19515588-Stroke,
pubmed-meshheading:19515588-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
The "other revolution" in stroke prevention.
|
pubmed:publicationType |
Editorial
|